The map and compass: integrating BD&L early to de- risk drug discovery
As AI -based diligence platforms evolve, data organisation and presentation will become increasingly important. Remco: Considering the risks of ...
Read the original at Drug Target Review ↗
- Tracked via
- “AI Risks”